Zhao Yuliang, Lin Feng, Yang Letian, Qiao Baiyu, Wang Yating, Yu Yang, Cui Tianlei, Fu Ping
Divison of Nephrology, West China Hospital of Sichuan University, Chengdu 610041, China.
Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China.
Ann Transl Med. 2020 May;8(10):640. doi: 10.21037/atm-20-3015.
Although the internal jugular vein (IJV) is the most widely used puncture site in hemodialysis catheter insertion and central vein angioplasty, the external jugular vein (EJV) offers an alternative vascular access point in cases when the IJV is inaccessible. The present study aims to observe the efficacy and safety of sharp recanalization of the brachiocephalic vein occlusion through the EJV in hemodialysis patients.
This retrospective study enrolled a cohort of hemodialysis patients who received sharp recanalization of occlusive brachiocephalic vein through the EJV at a university-affiliated hospital between January 2017 and January 2019. The demographic information and clinical outcome data of the patients were collected and analyzed.
A total of 16 hemodialysis patients who received right brachiocephalic vein sharp recanalization through the EJV were analyzed. The technical success rate was 100%. Twelve patients (12/16, 75%), whose EJV-subclavian vein angle (E-S angle) was 60-80 degrees, were successfully recanalized on the first attempt. With the other 4 patients (4/16, 25%), whose E-S angle approached 90 degrees, the brachiocephalic vein was recanalized on the second attempt by elevating the ipsilateral shoulder, therefore decreasing the E-S angle to align the course of the EJV with the brachiocephalic vein. Three minor complications were recorded, including 1 patient with blood continuously oozing from the EJV at the puncture site and 2 patients with mild chest pain. After an average of 10 months of follow-up, the clinical patent rate was 81.25% with no procedure-related complications reported.
Sharp recanalization through the EJV could be an effective and safe alternative treatment for right brachiocephalic vein occlusion in hemodialysis patients if performed by an experienced practitioner. Measuring the angle formed by the EJV and the subclavian vein might provide helpful information for selecting patients.
尽管颈内静脉(IJV)是血液透析导管插入术和中心静脉血管成形术中最常用的穿刺部位,但在颈内静脉无法使用时,颈外静脉(EJV)可作为另一种血管通路点。本研究旨在观察在血液透析患者中经颈外静脉对头臂静脉闭塞进行锐性再通的疗效和安全性。
这项回顾性研究纳入了一组在2017年1月至2019年1月期间于某大学附属医院接受经颈外静脉对头臂静脉闭塞进行锐性再通的血液透析患者。收集并分析患者的人口统计学信息和临床结局数据。
共分析了16例接受经颈外静脉对头臂静脉进行锐性再通的血液透析患者。技术成功率为100%。12例患者(12/16,75%),其颈外静脉-锁骨下静脉夹角(E-S角)为60-80度,首次尝试即成功再通。另外4例患者(4/16,25%),其E-S角接近90度,通过抬高同侧肩部,使E-S角减小,使颈外静脉与头臂静脉走行对齐,第二次尝试时成功再通头臂静脉。记录到3例轻微并发症,包括1例穿刺部位颈外静脉持续渗血患者和2例轻度胸痛患者。平均随访10个月后,临床通畅率为81.25%,未报告与手术相关的并发症。
如果由经验丰富的医生进行操作,经颈外静脉锐性再通可能是血液透析患者右头臂静脉闭塞的一种有效且安全的替代治疗方法。测量颈外静脉与锁骨下静脉形成的夹角可能为选择患者提供有用信息。